Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Quality Index
Xizang Haisco Pharmaceutical Group Co Ltd cash flow quality index. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of CN¥39.68 Million is below net income of CN¥166.48 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 002653 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Cash flow quality index of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. Historical Cash Flow Quality Index for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 002653 equity to assets ratio to measure how much of total assets are equity-financed.
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (2008–2025)
Xizang Haisco Pharmaceutical Group Co Ltd cash flow quality index by year from 2008 to 2025. Year-by-year earnings quality comparison for Xizang Haisco Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Xizang Haisco Pharmaceutical Group Co Lt (002653) cash conversion ratio.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.03x | CN¥786.00 Million | CN¥259.58 Million | ▲ +219.3% |
| 2024 | 0.95x | CN¥442.05 Million | CN¥466.20 Million | ▼ -37.7% |
| 2023 | 1.52x | CN¥449.58 Million | CN¥295.56 Million | ▲ +530.1% |
| 2022 | 0.24x | CN¥94.55 Million | CN¥391.64 Million | ▲ +249.0% |
| 2021 | 0.07x | CN¥35.80 Million | CN¥517.58 Million | ▼ -79.8% |
| 2020 | 0.34x | CN¥206.21 Million | CN¥601.20 Million | ▼ -78.7% |
| 2019 | 1.61x | CN¥764.26 Million | CN¥474.85 Million | ▲ +13.5% |
| 2018 | 1.42x | CN¥472.61 Million | CN¥333.23 Million | ▼ -14.0% |
| 2017 | 1.65x | CN¥391.81 Million | CN¥237.55 Million | ▲ +78.5% |
| 2016 | 0.92x | CN¥409.20 Million | CN¥442.78 Million | ▼ -22.4% |
| 2015 | 1.19x | CN¥443.03 Million | CN¥372.16 Million | ▲ +6.7% |
| 2014 | 1.12x | CN¥502.57 Million | CN¥450.54 Million | ▲ +1.9% |
| 2013 | 1.09x | CN¥568.41 Million | CN¥519.22 Million | ▲ +4.4% |
| 2012 | 1.05x | CN¥464.75 Million | CN¥443.06 Million | ▲ +25.6% |
| 2011 | 0.84x | CN¥260.79 Million | CN¥312.30 Million | ▼ -30.5% |
| 2010 | 1.20x | CN¥367.38 Million | CN¥305.75 Million | ▼ -7.4% |
| 2009 | 1.30x | CN¥368.21 Million | CN¥283.72 Million | ▲ +168.1% |
| 2008 | 0.48x | CN¥94.45 Million | CN¥195.09 Million | — |